Life Sciences

Novo says oral version of obesity drug succeeds in larg...

Novo Nordisk has announced that an oral form of semaglutide, the medication mark...

New variation of the once-obsolete streptothricin shows...

Scientists have been on the lookout for antibiotics against multidrug-resistant ...

Krystal Biotech Gains FDA Green Light For Skin-Disorder...

Vyjuvek, a medication developed by Krystal Biotech, has become the first therapy...

Sanofi finds success in clinical trial for smoker’s lungs

Sanofi has emphasized the rapid and sustained benefits of its collaborative anti...

FTC sues to block Amgen’s $27.8B deal for Horizon

The Federal Trade Commission (FTC) is questioning Amgen’s $27.8 billion acquisit...

Healthcare-focused startup secures $50M from General Ca...

Healthcare startup Hippocratic AI has emerged with $50 million in funding to dev...

UniQure sells hemophilia gene therapy royalty rights

UniQure made an announcement that it has sold a portion of the royalties worth $...

FDA approves drug for night sweats and hot flashes trea...

The FDA announced on Friday that a new non-hormonal medication, Veozah, also kno...

IntraOp Announces Phase II Trial for Carcinoma Therapy

IntraOp Medical Corporation has announced the second phase of the first-ever Ele...

Nido’s precision approach to brain drugs secures $109M ...

Amid the difficulties of the biotech market at present, investors are inclined t...

Bayer Signs 2nd $1.7B Deal in 2 Months with a Focus on ...

Two months after partnering with Novartis for its radio-conjugates, UK-based Bic...

Gilead acquires San Diego start-up for early-stage cancer

Gilead has acquired a San Diego start-up for early-stage cancer and immune drugs...

FDA Gives Green Light to Eyenovia’s Pupil-Dilating Spray

Eyenovia Inc. – an ophthalmic technology firm setting up the Optejet equipment f...

FDA cites quality issues at Rentschler and Eli Lilly fa...

The FDA has raised concerns publicly following inspections of Eli Lilly and Rent...

Virogenetics Inc. Announces Pilot Clinical Trial of Dia...

Enzolytics, Inc., made an announcement recently that its wholly-owned subsidiary...

FDA Doubtful Over Benefit of Sarepta’s Duchenne Gene Th...

It is unclear if the first gene therapy for Duchenne muscular dystrophy will be ...